Fractyl Health Statistics
Total Valuation
Fractyl Health has a market cap or net worth of $136.53 million. The enterprise value is $149.00 million.
Important Dates
The last earnings date was Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Fractyl Health has 158.65 million shares outstanding. The number of shares has increased by 113.62% in one year.
| Current Share Class | 158.65M |
| Shares Outstanding | 158.65M |
| Shares Change (YoY) | +113.62% |
| Shares Change (QoQ) | +12.77% |
| Owned by Insiders (%) | 1.16% |
| Owned by Institutions (%) | 65.58% |
| Float | 145.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.84 |
| P/TBV Ratio | 7.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.28, with a Debt / Equity ratio of 2.84.
| Current Ratio | 4.28 |
| Quick Ratio | 4.10 |
| Debt / Equity | 2.84 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -778.33% and return on invested capital (ROIC) is -77.40%.
| Return on Equity (ROE) | -778.33% |
| Return on Assets (ROA) | -63.64% |
| Return on Invested Capital (ROIC) | -77.40% |
| Return on Capital Employed (ROCE) | -110.60% |
| Weighted Average Cost of Capital (WACC) | 11.29% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.08M |
| Employee Count | 100 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.93% in the last 52 weeks. The beta is 2.11, so Fractyl Health's price volatility has been higher than the market average.
| Beta (5Y) | 2.11 |
| 52-Week Price Change | -43.93% |
| 50-Day Moving Average | 0.56 |
| 200-Day Moving Average | 1.13 |
| Relative Strength Index (RSI) | 65.84 |
| Average Volume (20 Days) | 2,469,631 |
Short Selling Information
The latest short interest is 3.01 million, so 1.89% of the outstanding shares have been sold short.
| Short Interest | 3.01M |
| Short Previous Month | 3.89M |
| Short % of Shares Out | 1.89% |
| Short % of Float | 2.06% |
| Short Ratio (days to cover) | 1.81 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -92.88M |
| Pretax Income | -108.00M |
| Net Income | -108.00M |
| EBITDA | -91.76M |
| EBIT | -92.88M |
| Earnings Per Share (EPS) | -$1.05 |
Full Income StatementBalance Sheet
The company has $63.17 million in cash and $60.82 million in debt, with a net cash position of $2.35 million or $0.01 per share.
| Cash & Cash Equivalents | 63.17M |
| Total Debt | 60.82M |
| Net Cash | 2.35M |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | 21.38M |
| Book Value Per Share | 0.14 |
| Working Capital | 50.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$87.73 million and capital expenditures -$109,000, giving a free cash flow of -$87.84 million.
| Operating Cash Flow | -87.73M |
| Capital Expenditures | -109,000 |
| Depreciation & Amortization | 1.12M |
| Net Borrowing | -471,000 |
| Free Cash Flow | -87.84M |
| FCF Per Share | -$0.55 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Fractyl Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -113.62% |
| Shareholder Yield | -113.62% |
| Earnings Yield | -71.36% |
| FCF Yield | -58.03% |
Analyst Forecast
The average price target for Fractyl Health is $5.40, which is 527.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.40 |
| Price Target Difference | 527.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
